4.7 Article

Development of novel monoclonal antibodies against starch and ulvan - implications for antibody production against polysaccharides with limited immunogenicity

期刊

SCIENTIFIC REPORTS
卷 7, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-017-04307-2

关键词

-

资金

  1. Danish Strategic Research Council
  2. Danish Council for Independent Research, Technology and Production Sciences under project GlycAct [10-093465]
  3. FP7 Marie Curie action project CeWalDyn [329830]
  4. Danish National Advanced Technology Foundation project B21st
  5. Danish Innovation Foundation
  6. Villum foundation project Planet project [00009283]
  7. US National Science Foundation (NSF) Molecular and Cellular Bioscience [0919925, 1517345]
  8. NSF Division of Biological Infrastructure [0922805]
  9. Carlsberg Foundation
  10. French National Research Agency program IDEALG [ANR-10-BTBR-04]
  11. Div Of Biological Infrastructure
  12. Direct For Biological Sciences [0922805] Funding Source: National Science Foundation
  13. Div Of Molecular and Cellular Bioscience
  14. Direct For Biological Sciences [1517345] Funding Source: National Science Foundation
  15. Div Of Molecular and Cellular Bioscience
  16. Direct For Biological Sciences [0919925] Funding Source: National Science Foundation

向作者/读者索取更多资源

Monoclonal antibodies (mAbs) are widely used and powerful research tools, but the generation of mAbs against glycan epitopes is generally more problematic than against proteins. This is especially significant for research on polysaccharide-rich land plants and algae (Viridiplantae). Most antibody production is based on using single antigens, however, there are significant gaps in the current repertoire of mAbs against some glycan targets with low immunogenicity. We approached mAb production in a different way and immunised with a complex mixture of polysaccharides. The multiplexed screening capability of carbohydrate microarrays was then exploited to deconvolute the specificities of individual mAbs. Using this strategy, we generated a set of novel mAbs, including one against starch (INCh1) and one against ulvan (INCh2). These polysaccharides are important storage and structural polymers respectively, but both are generally considered as having limited immunogenicity. INCh1 and INCh2 therefore represent important new molecular probes for Viridiplantae research. Moreover, since the alpha-(1-4)-glucan epitope recognised by INCh1 is also a component of glycogen, this mAb can also be used in mammalian systems. We describe the detailed characterisation of INCh1 and INCh2, and discuss the potential of a non-directed mass-screening approach for mAb production against some glycan targets.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据